Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1982 2
1984 1
1985 2
1986 2
1988 1
1989 2
1991 1
1992 1
1993 1
1994 1
1995 5
1996 1
1997 4
1998 2
1999 1
2000 3
2001 3
2003 2
2004 2
2006 1
2007 1
2018 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.
Richmond JM, Strassner JP, Zapata L Jr, Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, Harris JE. Richmond JM, et al. Among authors: tso jy. Sci Transl Med. 2018 Jul 18;10(450):eaam7710. doi: 10.1126/scitranslmed.aam7710. Sci Transl Med. 2018. PMID: 30021889 Free PMC article.
Humanization and characterization of the anti-HLA-DR antibody 1D10.
Kostelny SA, Link BK, Tso JY, Vasquez M, Jorgensen BH, Wang H, Hall WC, Weiner GJ. Kostelny SA, et al. Among authors: tso jy. Int J Cancer. 2001 Aug 15;93(4):556-65. doi: 10.1002/ijc.1366. Int J Cancer. 2001. PMID: 11477560 Free article.
Engineered human IgG antibodies with longer serum half-lives in primates.
Hinton PR, Johlfs MG, Xiong JM, Hanestad K, Ong KC, Bullock C, Keller S, Tang MT, Tso JY, Vásquez M, Tsurushita N. Hinton PR, et al. Among authors: tso jy. J Biol Chem. 2004 Feb 20;279(8):6213-6. doi: 10.1074/jbc.C300470200. Epub 2003 Dec 29. J Biol Chem. 2004. PMID: 14699147 Free article.
43 results